Supraphen Ophthalmic Solution

Introduction

Supraphen Ophthalmic Solution 5% is an antibiotic used in the treatment of various eye infections. It is a broad-spectrum antibiotic that can effectively target a wide range of bacterial pathogens. Ophthalmic formulations of chloramphenicol are applied directly to the eye to manage and treat infections affecting the cornea, conjunctiva, and other ocular tissues.

Uses

Chloramphenicol ophthalmic is primarily used for:

• Treating bacterial conjunctivitis (pink eye).
• Managing bacterial keratitis (corneal infection).
• Treating other superficial ocular infections caused by susceptible bacteria.

Mechanism of Action

Chloramphenicol works by inhibiting bacterial protein synthesis. It binds to the 50S subunit of the bacterial ribosome, preventing peptide bond formation and thereby disrupting bacterial protein synthesis. This action leads to the suppression of bacterial growth and eradication of the infection.

How Long Does It Take to Work?

Chloramphenicol ophthalmic generally starts to show improvement in symptoms within 24 to 48 hours of application. Full resolution of symptoms may take several days, depending on the severity of the infection and the patient’s response to treatment.

Absorption

When applied topically to the eye, chloramphenicol is minimally absorbed systemically. Most of the drug remains localized to the ocular surface where it exerts its antimicrobial effects.

Route of Elimination

Chloramphenicol is primarily eliminated through the liver. It undergoes conjugation and is excreted in the urine. Minimal systemic absorption from ophthalmic use means that the majority of the drug is eliminated from the ocular surface or excreted in the urine if absorbed systemically.

Dosage

The dosage of chloramphenicol ophthalmic typically involves:

• Instilling 1-2 drops into the affected eye(s) every 2-4 hours during the day for the first 48 hours, then reducing the frequency based on the clinical response.
• The exact dosage and duration of treatment should be determined by a healthcare provider based on the severity of the infection and patient response.

Administration

To use chloramphenicol ophthalmic:

• Wash your hands thoroughly before applying the medication.
• Instill the prescribed number of drops into the affected eye(s), avoiding contact of the dropper tip with any surface to prevent contamination.
• Close the eye gently and press the corner of the eye near the nose to minimize systemic absorption and enhance drug efficacy.

Side Effects

Common side effects may include:

• Temporary stinging or burning sensation in the eye.
• Redness or itching of the eye.

Serious side effects may include:

• Allergic reactions such as rash, swelling, or difficulty breathing.
• Severe ocular irritation or vision changes.

Toxicity

Signs of toxicity are rare with ophthalmic use but may include severe allergic reactions or significant ocular irritation. In case of overdose or severe symptoms, discontinue use and seek medical attention immediately.

Precautions

Precautions include:

• Avoid using in patients with a history of hypersensitivity to chloramphenicol or any other component of the formulation.
• Use with caution in patients with pre-existing eye conditions or those who have had recent eye surgery.
• Do not use for prolonged periods or in high doses to avoid potential adverse effects.

Interaction

Topical chloramphenicol generally has minimal systemic interactions due to its localized application. However, concurrent use with other ophthalmic medications should be managed carefully to avoid potential interactions.

Disease Interaction

Use cautiously in patients with:

• Pre-existing liver impairment.
• Pre-existing renal impairment.
• Active or history of severe ocular infections.

Drug Interaction

Chloramphenicol ophthalmic may interact with other systemic antibiotics or medications metabolized by the liver, though systemic interactions are minimal with topical use. Always inform your healthcare provider of all medications you are using.

Food Interactions

There are no known significant food interactions with chloramphenicol ophthalmic. However, maintaining good general eye hygiene is advisable to support treatment effectiveness.

Pregnancy Use

Chloramphenicol ophthalmic is classified as pregnancy category C. The use of this medication during pregnancy should be considered only if the potential benefits outweigh the risks. Consult with a healthcare provider before using this medication if you are pregnant.

Lactation Use

It is not known if chloramphenicol ophthalmic is excreted in breast milk. Caution should be exercised when administering the medication to breastfeeding mothers. Consult a healthcare provider for guidance.

Acute Overdose

Acute overdose from topical application is unlikely. In the event of accidental ingestion or severe systemic reactions, seek immediate medical attention.

Contraindication

Chloramphenicol ophthalmic is contraindicated in individuals with:

• Hypersensitivity to chloramphenicol or any of its components.
• Severe eye infections that may require systemic treatment.

Use Direction

Follow the prescribed dosage and administration instructions provided by your healthcare provider. Do not use more frequently than directed, and do not discontinue treatment prematurely. If symptoms persist or worsen, seek medical advice.

Storage Conditions

Store chloramphenicol ophthalmic at room temperature, away from moisture and heat. Do not freeze. Keep the medication in its original container and out of reach of children.

Volume of Distribution

The volume of distribution for topical chloramphenicol is not well-defined due to its localized application. Systemic absorption is minimal, with the drug mainly remaining at the ocular surface.

Half Life

The half-life of chloramphenicol following topical application is not well-established. The systemic absorption from ophthalmic use is minimal, so systemic pharmacokinetic parameters are less relevant for topical formulations.

Clearance

Chloramphenicol is primarily cleared through hepatic metabolism and renal excretion. Minimal systemic absorption from the ophthalmic formulation reduces systemic clearance considerations.